These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1411629)

  • 1. Phase I/II study of simultaneous carboplatin and radiotherapy in unresectable squamous cell carcinoma of the head and neck.
    Volling P; Staar S; Achterrath W; Müller RP
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):66-71. PubMed ID: 1411629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin plus radiation therapy in head and neck cancer.
    Volling P; Staar S; Achterrath W; Müller RP
    Semin Oncol; 1991 Feb; 18(1 Suppl 2):17-22. PubMed ID: 1992531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged continuous infusion of carboplatin and concomitant radiotherapy in advanced head and neck cancer. A phase I study.
    Ausili-Cèfaro G; Marmiroli L; Nardone L; Salvi G
    Am J Clin Oncol; 1995 Jun; 18(3):273-6. PubMed ID: 7747718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous radiotherapy and chemotherapy with carboplatin in inoperable squamous cell carcinoma of the head and neck: a phase II study.
    Zamboglou N; Achterrath W; Schnabel T; Lenaz L; Kolotas C; Schmitt G
    Cancer Invest; 1992; 10(5):349-55. PubMed ID: 1393686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of hyperfractionated accelerated radiation and simultaneous Carboplatin therapy for advanced head and neck carcinomas.
    Schnabel T; Zamboglou N; Kolotas C; Jiménez W; Strehl H; Schmitt G
    Strahlenther Onkol; 1992 Jun; 168(6):318-21. PubMed ID: 1621209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study.
    Airoldi M; Cattel L; Cortesina G; Giordano C; Pedani F; Recalenda V; Danova M; Gabriele AM; Tagini V; Porta C; Bumma C
    Am J Clin Oncol; 2004 Apr; 27(2):155-63. PubMed ID: 15057155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer. Definitive results of a phase I-II study.
    Orecchia R; Ragona R; Airoldi M; Gabriele P; Gribaudo S; Grazia Ruo Redda M; Bussi M; Cavalot A; Rampino M; Sannazzari GL
    Acta Oncol; 1994; 33(5):541-5. PubMed ID: 7917369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of concurrent carboplatin and radiotherapy in previously untreated patients with stage III and IV head and neck cancer.
    Osoba D; Flores AD; Hay JH; Wong F; Maher M
    Head Neck; 1991; 13(3):217-22; discussion 222-3. PubMed ID: 1903785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: a phase I-II study.
    Jacobs MC; Eisenberger M; Oh MC; Sinibaldi V; Gray W; Elias G; Salazar OM
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):361-3. PubMed ID: 2666366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.